• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全视野刺激测试:在临床中的作用以及作为重度儿童视网膜疾病临床试验的一项结局指标。

Full-field stimulus testing: Role in the clinic and as an outcome measure in clinical trials of severe childhood retinal disease.

作者信息

Roman Alejandro J, Cideciyan Artur V, Wu Vivian, Garafalo Alexandra V, Jacobson Samuel G

机构信息

Scheie Eye Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.

Scheie Eye Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.

出版信息

Prog Retin Eye Res. 2022 Mar;87:101000. doi: 10.1016/j.preteyeres.2021.101000. Epub 2021 Aug 28.

DOI:10.1016/j.preteyeres.2021.101000
PMID:34464742
Abstract

Disease mechanisms have become better understood in previously incurable forms of early-onset severe retinal dystrophy, such as Leber congenital amaurosis (LCA). This has led to novel treatments and clinical trials that have shown some success. Standard methods to measure vision were difficult if not impossible to perform in severely affected patients with low vision and nystagmus. To meet the need for visual assays, we devised a psychophysical method, which we named full-field stimulus testing (FST). From early versions based on an automated perimeter, we advanced FST to a more available light-emitting diode platform. The journey from invention to use of such a technique in our inherited retinal degeneration clinic is reviewed and many of the lessons learned over the 15 years of application of FST are explained. Although the original purpose and application of FST was to quantify visual thresholds in LCA, there are rare opportunities for FST also to be used beyond LCA to measure aspects of vision in other inherited retinal degenerations; examples are given. The main goal of the current review, however, remains to enable investigators studying and treating LCA to understand how to best use FST and how to reduce artefact and confounding complexities so the test results become more valuable to the understanding of LCA diseases and results of novel interventions.

摘要

在诸如莱伯先天性黑蒙(LCA)等以前无法治愈的早发性严重视网膜营养不良形式中,疾病机制已得到更好的理解。这催生了新的治疗方法和临床试验,并取得了一些成功。对于视力严重受损且伴有眼球震颤的患者,即便不是不可能,采用标准方法测量视力也十分困难。为满足视觉检测的需求,我们设计了一种心理物理学方法,将其命名为全视野刺激测试(FST)。从基于自动视野计的早期版本开始,我们将FST改进为更通用的发光二极管平台。本文回顾了从这项技术的发明到在我们的遗传性视网膜变性诊所应用的历程,并解释了在FST应用的15年中汲取的许多经验教训。尽管FST的最初目的和应用是量化LCA中的视觉阈值,但在LCA之外,FST也有罕见的机会用于测量其他遗传性视网膜变性的视力方面;文中给出了相关示例。然而,本次综述的主要目标仍然是使研究和治疗LCA的研究人员了解如何最佳地使用FST,以及如何减少假象和混淆的复杂性,从而使测试结果对于理解LCA疾病和新干预措施的结果更具价值。

相似文献

1
Full-field stimulus testing: Role in the clinic and as an outcome measure in clinical trials of severe childhood retinal disease.全视野刺激测试:在临床中的作用以及作为重度儿童视网膜疾病临床试验的一项结局指标。
Prog Retin Eye Res. 2022 Mar;87:101000. doi: 10.1016/j.preteyeres.2021.101000. Epub 2021 Aug 28.
2
Mobility test to assess functional vision in dark-adapted patients with Leber congenital amaurosis.评估先天性黑矇性莱伯氏遗传性视神经病变患者暗适应功能视力的活动测试。
BMC Ophthalmol. 2022 Jun 14;22(1):266. doi: 10.1186/s12886-022-02475-y.
3
Leber congenital amaurosis/early-onset severe retinal dystrophy: clinical features, molecular genetics and therapeutic interventions.莱伯先天性黑蒙/早发性严重视网膜营养不良:临床特征、分子遗传学及治疗干预措施
Br J Ophthalmol. 2017 Sep;101(9):1147-1154. doi: 10.1136/bjophthalmol-2016-309975. Epub 2017 Jul 8.
4
Leber congenital amaurosis/early-onset severe retinal dystrophy: current management and clinical trials.Leber 先天性黑矇/早发性严重视网膜营养不良:当前的治疗方法和临床试验。
Br J Ophthalmol. 2022 Apr;106(4):445-451. doi: 10.1136/bjophthalmol-2020-318483. Epub 2021 Mar 12.
5
Defining Outcomes for Clinical Trials of Leber Congenital Amaurosis Caused by GUCY2D Mutations.定义由GUCY2D突变引起的莱伯先天性黑蒙临床试验的结果。
Am J Ophthalmol. 2017 May;177:44-57. doi: 10.1016/j.ajo.2017.02.003. Epub 2017 Feb 16.
6
An Update on Gene Therapy for Inherited Retinal Dystrophy: Experience in Leber Congenital Amaurosis Clinical Trials.遗传性视网膜营养不良的基因治疗进展:Leber 先天性黑矇临床试验经验。
Int J Mol Sci. 2021 Apr 26;22(9):4534. doi: 10.3390/ijms22094534.
7
Screening of SPATA7 in patients with Leber congenital amaurosis and severe childhood-onset retinal dystrophy reveals disease-causing mutations.对先天性黑蒙 10 型和严重儿童期起病的视网膜营养不良患者的 SPATA7 进行筛查,揭示了致病突变。
Invest Ophthalmol Vis Sci. 2011 May 9;52(6):3032-8. doi: 10.1167/iovs.10-7025.
8
Leber congenital amaurosis: Current genetic basis, scope for genetic testing and personalized medicine.Leber 先天性黑矇:当前的遗传基础、基因检测范围和个性化医疗。
Exp Eye Res. 2019 Dec;189:107834. doi: 10.1016/j.exer.2019.107834. Epub 2019 Oct 19.
9
The phenotype of Severe Early Childhood Onset Retinal Dystrophy (SECORD) from mutation of RPE65 and differentiation from Leber congenital amaurosis.RPE65 基因突变致严重婴幼儿期起病的视网膜色素变性表型及其与莱伯先天性黑矇的鉴别。
Invest Ophthalmol Vis Sci. 2011 Jan 5;52(1):292-302. doi: 10.1167/iovs.10-6106.
10
Outcome measure for the treatment of cone photoreceptor diseases: orientation to a scene with cone-only contrast.锥状光感受器疾病治疗的结果指标:仅基于锥状细胞对比度的场景定向。
BMC Ophthalmol. 2015 Aug 8;15:98. doi: 10.1186/s12886-015-0085-0.

引用本文的文献

1
Efficacy and Safety of Voretigene Neparvovec in -Retinopathy: Results of a Phase III Trial in Japan.维替泊汀治疗视网膜病变的疗效与安全性:日本一项III期试验的结果
Ophthalmol Sci. 2025 Jul 7;5(6):100876. doi: 10.1016/j.xops.2025.100876. eCollection 2025 Nov-Dec.
2
Short-Term Outcomes of Pediatric Patients With Mild Autosomal Recessive RPE65-Associated Retinal Dystrophy Treated With Voretigene Neparvovec.用维替泊芬治疗的轻度常染色体隐性RPE65相关视网膜营养不良儿科患者的短期预后
Transl Vis Sci Technol. 2025 Aug 1;14(8):8. doi: 10.1167/tvst.14.8.8.
3
Retinal Degeneration Associated With Biallelic RDH12 Variants: Longitudinal Evaluation of Retinal Structure and Visual Function in Pediatric Patients.
与双等位基因RDH12变异相关的视网膜变性:儿科患者视网膜结构和视觉功能的纵向评估
Invest Ophthalmol Vis Sci. 2024 Dec 2;65(14):30. doi: 10.1167/iovs.65.14.30.
4
Relationship between the full-field stimulus test and self-reported visual function in patients with retinitis pigmentosa: REPEAT Study report No. 3.视网膜色素变性患者全视野刺激试验与自我报告的视觉功能之间的关系:重复研究报告第3号
Acta Ophthalmol. 2025 Jun;103(4):396-403. doi: 10.1111/aos.17427. Epub 2024 Dec 12.
5
THE FIGHT INHERITED RETINAL BLINDNESS! PROJECT: A New Treatment Outcome and Natural History Registry for Inherited Retinal Disease.对抗遗传性视网膜失明!项目:遗传性视网膜疾病的新治疗结果与自然病史登记处。
Retina. 2025 Feb 1;45(2):286-295. doi: 10.1097/IAE.0000000000004296.
6
Exploring Scotopic Microperimetry as an Outcome Measure in Choroideremia.探讨暗视野微视野计在脉络膜黑矇症中的应用作为一种结局指标。
Transl Vis Sci Technol. 2024 Sep 3;13(9):29. doi: 10.1167/tvst.13.9.29.
7
Update on Clinical Trial Endpoints in Gene Therapy Trials for Inherited Retinal Diseases.遗传性视网膜疾病基因治疗试验的临床试验终点更新
J Clin Med. 2024 Sep 18;13(18):5512. doi: 10.3390/jcm13185512.
8
Twelve-month Natural History Study of Centrosomal Protein 290 (CEP290)-associated Inherited Retinal Degeneration.中心体蛋白290(CEP290)相关遗传性视网膜变性的12个月自然史研究
Ophthalmol Sci. 2024 Feb 7;4(5):100483. doi: 10.1016/j.xops.2024.100483. eCollection 2024 Sep-Oct.
9
Gene Editing for -Associated Retinal Degeneration.基因编辑治疗与相关的视网膜退行性病变。
N Engl J Med. 2024 Jun 6;390(21):1972-1984. doi: 10.1056/NEJMoa2309915. Epub 2024 May 6.
10
Comparison of Full-Field Stimulus Threshold Measurements in Patients With Retinitis Pigmentosa and Healthy Subjects With Dilated and Nondilated Pupil.全视野刺激阈值测量在色素性视网膜炎患者和瞳孔扩大和未扩瞳孔的健康受试者中的比较。
Transl Vis Sci Technol. 2024 Apr 2;13(4):23. doi: 10.1167/tvst.13.4.23.